NCT05081063: A trial that was reported late by Loma Linda University
This trial has reported, although it was 385 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT05081063 |
|---|---|
| Title | Low-Titer O Positive Whole Blood Versus Component Therapy for Emergent Transfusion in Trauma Patients |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | March 5, 2022 |
| Completion date | May 15, 2023 |
| Required reporting date | May 14, 2024, midnight |
| Actual reporting date | June 4, 2025 |
| Date last checked at ClinicalTrials.gov | April 29, 2026 |
| Days late | 385 |